SLC31A1 and prostate carcinoma: Some of these studies have revealed a significantly higher expression of hCTR1 in malignant tissues than normal tissues, including prostate cancer, lung cancer, glioblastomas, liver cancer, breast cancer, and melanoma [5,11].